Exact Mass: 391.10895260000007
Exact Mass Matches: 391.10895260000007
Found 35 metabolites which its exact mass value is equals to given mass value 391.10895260000007
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Chlorohaloperidol
Zidebactam
C13H21N5O7S (391.11616360000005)
[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-
(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE
1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine
C12H20F3N3O6S (391.1024856000001)
2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-
C20H22ClNO5 (391.11864320000007)
(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE
Zidebactam
C13H21N5O7S (391.11616360000005)
C254 - Anti-Infective Agent > C258 - Antibiotic
Tavapadon
C19H16F3N3O3 (391.11437020000005)
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].
n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide
C19H21NO6S (391.10895260000007)
2-(glutathion-S-yl)-2-carboxypropane
C14H21N3O8S-2 (391.10493060000005)
N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide
C21H17N3O3S (391.09905720000006)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)